Eye-care giant Alcon Inc. is buying health care group WaveTec Vision Inc.
WaveTec, headquartered in Aliso Viejo, California, developed the Ora System, a commercialized intra-operative guidance system used by cataract surgeons who are implanting intraocular lenses. The system provides measurements that aren't available with pre-operative technologies.
Alcon plans to integrate the technology into its existing cataract offerings, which include Verion and LenSx and other products.
Fort Worth, Texas-based Alcon provides surgical, pharmaceutical and vision-related eye care products. The company is a division of Novartis Group (NYSE: NVS), which is headquartered in Basel, Switzerland.
Hogan Lovells partners Adam Golden and Jodi Scott advised Alcon on the deal.
Other recent eye care transactions include Valeant Pharmaceuticals International Inc.'s $8.7 billion deal for Bausch & Lomb Holdings Inc. and Thomas H. Lee's acquisition of 1-800-Contacts.
For more on health care technology adding to M&A, see "5 Technologies Drive Health Care M&A."